WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015

Feb 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-23

Reporting Person: Lennartz Heino (President Europe)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-23	Common Stock	M	9458.0000	$21.2200	Acquired	39768.5600	Direct
2015-02-23	Common Stock	M	8582.0000	$20.4250	Acquired	48350.5600	Direct
2015-02-23	Common Stock	S	3000.0000	$53.5619	Disposed	45350.5600	Direct
2015-02-23	Common Stock	S	8582.0000	$53.4100	Disposed	36768.5600	Direct
2015-02-23	Common Stock	S	9458.0000	$53.3500	Disposed	27310.5600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-23	Stock Option (Right to Buy)	$21.2200	M	9458.0000	Disposed	2022-02-21	Common Stock (9458.0000)	Direct
2015-02-23	Stock Option (Right to Buy)	$20.4250	M	8582.0000	Disposed	2021-02-21	Common Stock (8582.0000)	Direct

Footnotes

F1: This was multiple transactions on the same date with prices in the range of $53.01to $53.60. The undersigned hereby undertakes to provide upon request to the Securities and Exchange Commission, the issuer or any security holder of the issuer on request, full information regarding the number of shares purchased or sold at each separate price.